Nuzenio

Ono Pharmaceutical Co

Ono Pharmaceutical Co news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases - BioSpaceBioSpace · Thu, 06 Aug 2026 12:41:31 GMT Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMT Mediar Therapeutics Enters Antibody Collaboration with Ono Pharma for Fibro-Inflammatory Diseases - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 07:00:00 GMT Ono Pharmaceutical Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:OPHLY) 2026-08-04 - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 23:04:33 GMT Enterprise value to revenue forward of ONO Pharmaceutical Co., Ltd. – TSE:4528 - TradingViewTradingView · Sat, 01 Aug 2026 04:15:36 GMT ONO Pharmaceutical Co Ltd (ON4) Q4 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 01 Aug 2026 01:17:21 GMT ONO Pharmaceutical Co Ltd (ON4) Q2 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 01 Aug 2026 01:16:31 GMT ONO Pharmaceutical Co Ltd (ON4) Q3 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 01 Aug 2026 00:31:34 GMT

Timeline

Thu, 06 Aug 2026 12:41:31 GMTOno Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases - BioSpace

Thu, 06 Aug 2026 11:00:00 GMTMediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR Newswire

Thu, 06 Aug 2026 07:00:00 GMTMediar Therapeutics Enters Antibody Collaboration with Ono Pharma for Fibro-Inflammatory Diseases - BioPharm International

Tue, 04 Aug 2026 23:04:33 GMTOno Pharmaceutical Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:OPHLY) 2026-08-04 - Seeking Alpha

Sat, 01 Aug 2026 04:15:36 GMTEnterprise value to revenue forward of ONO Pharmaceutical Co., Ltd. – TSE:4528 - TradingView

Sat, 01 Aug 2026 01:17:21 GMTONO Pharmaceutical Co Ltd (ON4) Q4 2024 Earnings Report - Results, Call & Slides - TipRanks

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Results10 live mentions Ltd8 live mentions Earnings Report8 live mentions Call8 live mentions Fibro6 live mentions OPHLF6 live mentions Ono Pharma5 live mentions Slides4 live mentions TipRanks ONO Pharmaceutical4 live mentions Co Ltd4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ono Pharmaceutical Co.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.